drugset / Trial / NCT05038631

Managed Access Programs for LEE011, Ribociclib

NCT05038631

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to LEE011, Ribociclib

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Ribociclib Small molecule

Indications